Abstract
Raf kinase inhibitory protein (RKIP) was initially identified as phosphatidylethanolamine binding protein in bovine brain. It was later identified as a protein that inhibits Raf kinase activation of MEK. Further exploration has revealed that RKIP modulates several other signaling pathways including NF–κB and G-protein signaling. A gene array screen revealed that RKIP expression was low in a metastatic compared with non-metastatic prostate cancer cell line. Further experiments revealed that RKIP fits the criteria for a metastasis suppressor gene. RKIP expression has been shown to be downregulated in metastatic tissues, compared with non-metastatic tissue in multiple cancers, suggesting that loss of RKIP metastasis suppressor activity is a broad mechanism leading to metastasis. Additionally, loss of RKIP has been shown to impact therapy through conferring radioresistance and chemoresistance. Taken together, these data indicate understanding RKIP’s contributions to cancer may lead to important therapeutic strategies to prevent metastasis and promote therapeutic efficacy.
Similar content being viewed by others
References
Bernier, I., & Jolles, P. (1984). Purification and characterization of a basic 23 kDa cytosolic protein from bovine brain. Biochimica et Biophysica Acta, 790(2), 174–181.
Perry, A. C., Hall, L., Bell, A. E., & Jones, R. (1994). Sequence analysis of a mammalian phospholipid-binding protein from testis and epididymis and its distribution between spermatozoa and extracellular secretions. Biochemical Journal, 301(Pt 1), 235–242.
Grandy, D. K., Hanneman, E., Bunzow, J., Shih, M., Machida, C. A., Bidlack, J. M., et al. (1990). Purification, cloning, and tissue distribution of a 23-kDa rat protein isolated by morphine affinity chromatography. Molecular Endocrinology, 4(9), 1370–1376.
Bollengier, F., & Mahler, A. (1988). Localization of the novel neuropolypeptide h3 in subsets of tissues from different species. Journal of Neurochemistry, 50(4), 1210–1214.
Hori, N., Chae, K. S., Murakawa, K., Matoba, R., Fukushima, A., Okubo, K., et al. (1994). A human cDNA sequence homologue of bovine phosphatidylethanolamine-binding protein. Gene, 140(2), 293–294.
Seddiqi, N., Bollengier, F., Alliel, P. M., Perin, J. P., Bonnet, F., Bucquoy, S., et al. (1994). Amino acid sequence of the Homo sapiens brain 21–23-kDa protein (neuropolypeptide h3), comparison with its counterparts from Rattus norvegicus and Bos taurus species, and expression of its mRNA in different tissues. Journal of Molecular Evolution, 39(6), 655–660.
Banfield, M. J., Barker, J. J., Perry, A. C., & Brady, R. L. (1998). Function from structure? The crystal structure of human phosphatidylethanolamine-binding protein suggests a role in membrane signal transduction. Structure, 6(10), 1245–1254.
Fu, Z., Smith, P. C., Zhang, L., Rubin, M. A., Dunn, R. L., Yao, Z., et al. (2003). Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis. Journal of the National Cancer Institute, 95(12), 878–889.
Simister, P. C., Banfield, M. J., & Brady, R. L. (2002). The crystal structure of PEBP-2, a homologue of the PEBP/RKIP family. Acta Crystallographica Section D: Biological Crystallography, 58(Pt 6 Pt 2), 1077–1080.
Park, S., Yeung, M. L., Beach, S., Shields, J. M., & Yeung, K. C. (2005). RKIP downregulates B-Raf kinase activity in melanoma cancer cells. Oncogene, 24, 3535–3540.
Yeung, K., Seitz, T., Li, S., Janosch, P., McFerran, B., Kaiser, C., et al. (1999). Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP. Nature, 401(6749), 173–177. doi:10.1038/43686.
Yeung, K. C., Rose, D. W., Dhillon, A. S., Yaros, D., Gustafsson, M., Chatterjee, D., et al. (2001). Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation. Molecular and Cellular Biology, 21(21), 7207–7217.
Park, S., Rath, O., Beach, S., Xiang, X., Kelly, S. M., Luo, Z., et al. (2006). Regulation of RKIP binding to the N-region of the Raf-1 kinase. FEBS Letters, 580(27), 6405–6412.
Rath, O., Park, S., Tang, H. H., Banfield, M. J., Brady, R. L., Lee, Y. C., et al. (2008). The RKIP (Raf-1 kinase inhibitor protein) conserved pocket binds to the phosphorylated N-region of Raf-1 and inhibits the Raf-1-mediated activated phosphorylation of MEK. Cellular Signalling, 20(5), 935–941.
Yeung, K., Janosch, P., McFerran, B., Rose, D. W., Mischak, H., Sedivy, J. M., et al. (2000). Mechanism of suppression of the Raf/MEK/extracellular signal-regulated kinase pathway by the Raf kinase inhibitor protein. Molecular and Cellular Biology, 20(9), 3079–3085.
Al-Mulla, F., Bitar, M. S., Al-Maghrebi, M., Behbehani, A. I., Al-Ali, W., Rath, O., et al. (2011). Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3beta. Cancer Research, 71(4), 1334–1343.
Al-Mulla, F., Bitar, M. S., Feng, J., Park, S., & Yeung, K. C. (2012). A new model for Raf kinase inhibitory protein induced chemotherapeutic resistance. PLoS One, 7(1), e29532. doi:10.1371/journal.pone.0029532.
Chatterjee, D., Sabo, E., Tavares, R., & Resnick, M. B. (2008). Inverse association between Raf kinase inhibitory protein and signal transducers and activators of transcription 3 expression in gastric adenocarcinoma patients: Implications for clinical outcome. Clinical Cancer Research, 14(10), 2994–3001.
Lorenz, K., Lohse, M. J., & Quitterer, U. (2003). Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2. Nature, 426(6966), 574–579.
Tang, H., Park, S., Sun, S. C., Trumbly, R., Ren, G., Tsung, E., et al. (2010). RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex. FEBS Letters, 584(4), 662–668.
Corbit, K. C., Trakul, N., Eves, E. M., Diaz, B., Marshall, M., & Rosner, M. R. (2003). Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein. Journal of Biological Chemistry, 278(15), 13061–13068.
Germain, D., & Frank, D. A. (2007). Targeting the cytoplasmic and nuclear functions of signal transducers and activators of transcription 3 for cancer therapy. Clinical Cancer Research, 13(19), 5665–5669.
Al-Mulla, F., Hagan, S., Behbehani, A. I., Bitar, M. S., George, S. S., Going, J. J., et al. (2006). Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. Journal of Clinical Oncology, 24(36), 5672–5679.
Chatterjee, D., Bai, Y., Wang, Z., Beach, S., Mott, S., Roy, R., et al. (2004). RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis. Journal of Biological Chemistry, 279(17), 17515–17523.
Hagan, S., Al-Mulla, F., Mallon, E., Oien, K. A., Ferrier, R., Gusterson, B., et al. (2005). Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastases. Clinical Cancer Research 11:7392-7397.
Lee, H. C., Tian, B., Sedivy, J. M., Wands, J. R., & Kim, M. (2006). Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Gastroenterology, 131(4), 1208–1217.
Schuierer, M. M., Bataille, F., Hagan, S., Kolch, W., & Bosserhoff, A. K. (2004). Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines. Cancer Research, 64(15), 5186–5192.
Schuierer, M. M., Bataille, F., Weiss, T. S., Hellerbrand, C., & Bosserhoff, A. K. (2006). Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma. Oncology Reports, 16(3), 451–456.
Zhang, L., Fu, Z., Binkley, C., Giordano, T., Burant, C. F., Logsdon, C. D., et al. (2004). Raf kinase inhibitory protein inhibits beta-cell proliferation. Surgery, 136(3), 708–715.
Lopez, M., Maroc, N., Kerangueven, F., Bardin, F., Courcoul, M., Lavezzi, C., et al. (1991). Coexpression of the genes for interleukin 6 and its receptor without apparent involvement in the proliferation of acute myeloid leukemia cells. Experimental Hematology, 19, 797–803.
Martinho, O., Faloppa, C. C., Neto, C. S., Longatto-Filho, A., Baiocchi, G., da Cunha, I. W., et al. (2012). Loss of RKIP expression during the carcinogenic evolution of endometrial cancer. Journal of Clinical Pathology, 65(2), 122–128. doi:10.1136/jclinpath-2011-200358.
Jia, B., Liu, H., Kong, Q., & Li, B. (2012). RKIP expression associated with gastric cancer cell invasion and metastasis. Tumour Biology: The Journal of the International Society for Oncodevelopmental Biology and Medicine. doi:10.1007/s13277-012-0317-3.
Zaravinos, A., Chatziioannou, M., Lambrou, G. I., Boulalas, I., Delakas, D., & Spandidos, D. A. (2011). Implication of RAF and RKIP genes in urinary bladder cancer. Pathology Oncology Research: POR, 17(2), 181–190. doi:10.1007/s12253-010-9295-1.
Fu, Z., Kitagawa, Y., Shen, R., Shah, R., Mehra, R., Rhodes, D., et al. (2006). Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer. Prostate, 66(3), 248–256. doi:10.1002/pros.20319.
Beshir, A. B., Ren, G., Magpusao, A. N., Barone, L. M., Yeung, K. C., & Fenteany, G. (2010). Raf kinase inhibitor protein suppresses nuclear factor-kappaB-dependent cancer cell invasion through negative regulation of matrix metalloproteinase expression. Cancer Letters, 299(2), 137–149.
Dangi-Garimella, S., Yun, J., Eves, E. M., Newman, M., Erkeland, S. J., Hammond, S. M., et al. (2009). Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO Journal, 28(4), 347–358.
Martinho, O., Granja, S., Jaraquemada, T., Caeiro, C., Miranda-Goncalves, V., Honavar, M., et al. (2012). Downregulation of RKIP is associated with poor outcome and malignant progression in gliomas. PLoS One, 7(1), e30769. doi:10.1371/journal.pone.0030769.
Yun, J., Frankenberger, C. A., Kuo, W. L., Boelens, M. C., Eves, E. M., Cheng, N., et al. (2011). Signalling pathway for RKIP and Let-7 regulates and predicts metastatic breast cancer. EMBO Journal, 30(21), 4500–4514.
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999). Ras enhances Myc protein stability. Molecular Cell, 3(2), 169–179.
Xinzhou, H., Ning, Y., Ou, W., Xiaodan, L., Fumin, Y., Huitu, L., et al. (2011). RKIp inhibits the migration and invasion of human prostate cancer PC-3 M cells through regulation of extracellular matrix [Research Support, non-U.S.-Gov’t]. Molekuliarnaia Biologiia, 45(6), 1004–1011.
Baritaki, S., & Bonavida, B. (2010). Viral infection and cancer: The NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. Critical Reviews in Immunology, 30(1), 31–46.
Baritaki, S., Katsman, A., Chatterjee, D., Yeung, K. C., Spandidos, D. A., & Bonavida, B. (2007). Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. Journal of Immunology, 179, 5441–5453.
Baritaki, S., Yeung, K., Palladino, M., Berenson, J., & Bonavida, B. (2009). Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. Cancer Research, 69(21), 8376–8385.
Woods Ignatoski, K. M., Grewal, N. K., Markwart, S. M., Vellaichamy, A., Chinnaiyan, A. M., Yeung, K., et al. (2008). Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. International Journal of Radiation Oncology, Biology, and Physics, 72(1), 153–160.
Kobayashi, A., Ohta, T., & Yamamoto, M. (2004). Unique function of the Nrf2-Keap1 pathway in the inducible expression of antioxidant and detoxifying enzymes. Methods in Enzymology, 378, 273–286. doi:10.1016/S0076-6879(04)78021-0.
Lee, J. M., Calkins, M. J., Chan, K., Kan, Y. W., & Johnson, J. A. (2003). Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. Journal of Biological Chemistry, 278(14), 12029–12038. doi:10.1074/jbc.M211558200.
Venugopal, R., & Jaiswal, A. K. (1996). Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene. Proceedings of the National Academy of Sciences of the United States of America, 93(25), 14960–14965.
Thimmulappa, R. K., Mai, K. H., Srisuma, S., Kensler, T. W., Yamamoto, M., & Biswal, S. (2002). Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Research, 62(18), 5196–5203.
Hu, C. J., Zhou, L., Zhang, J., Huang, C., & Zhang, G. M. (2011). Immunohistochemical detection of Raf kinase inhibitor protein in normal cervical tissue and cervical cancer tissue. The Journal of International Medical Research, 39(1), 229–237.
Huerta-Yepez, S., Yoon, N. K., Hernandez-Cueto, A., Mah, V., Rivera-Pazos, C. M., Chatterjee, D., et al. (2011). Expression of phosphorylated raf kinase inhibitor protein (pRKIP) is a predictor of lung cancer survival. BMC Cancer, 11, 259. doi:10.1186/1471-2407-11-259.
Ruan, L., Wang, G. L., Yi, H., Chen, Y., Tang, C. E., Zhang, P. F., et al. (2010). Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy. [Research Support, non-U.S.-Gov’t]. Journal of Cellular Biochemistry, 110(4), 975–981. doi:10.1002/jcb.22611.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Escara-Wilke, J., Yeung, K. & Keller, E.T. Raf kinase inhibitor protein (RKIP) in cancer. Cancer Metastasis Rev 31, 615–620 (2012). https://doi.org/10.1007/s10555-012-9365-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10555-012-9365-9